[Federal Register Volume 70, Number 2 (Tuesday, January 4, 2005)]
[Notices]
[Page 390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-75]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on July 7, 2004, Chattem Chemicals Inc., 3801 St Elmo Avenue, 
Building 18, Chattanooga, Tennessee 37409, made application by renewal 
to the Drug Enforcement Administration (DEA) for registration as an 
importer of the basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)...................  I
2,5-Dimethoxyamphetamine (7396).............  I
4-Methoxyamphetamine (7411).................  I
Difenoxin (9168)............................  I
Methamphetamine (1105)......................  II
Raw Opium (9600)............................  II
Concentrate of Poppy Straw (9670)...........  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances for the manufacture of analytical reference 
standards.
    Any manufacturer who is presently, or is applying to be, registered 
with DEA to manufacture such basic classes of controlled substances may 
file comments or objections to the issuance of the proposed 
registration and may, at the same time, file a written request for a 
hearing on such application pursuant to 21 CFR 1301.43 and in such form 
as prescribed by 21 CFR 1316.47.
    Any such comments or objections or requests for hearing may be 
addressed, in quintuplicate, to the Deputy Assistant Administrator, 
Office of Diversion Control, Drug Enforcement Administration, United 
States Department of Justice, Washington, DC 20537, Attention: DEA 
Federal Register Representative, Office of Liaison and Policy (ODLR) 
and must be filed no later than February 3, 2005.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic class of any controlled substances in 
Schedule I or II are and will continue to be required to demonstrate to 
the Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration, that the requirements for such registration 
pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), 
(c), (d), (e) and (f) are satisfied.

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration,
[FR Doc. 05-75 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P